Extramedullary presentation of acute leukaemia: A case of myeloid/natural killer cell precursor leukaemia

Pathology

Volumn 35, Issue 4, 2003, Pages 325-329

  Chen, Vivien M Y ^a   McIlroy, Kirsten ^a,b   Loui, Jenny P Y ^b   Fay, Keith ^a,b   Ward, Christopher ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CD56 NCAM; Extramedullary acute leukemia; Granulocytic sarcoma of the breast; Immunophenotype; Myeloid natural killer cell leukaemia

Indexed keywords

ACUTE LEUKEMIA; ADULT; ARTICLE; BREAST BIOPSY; BREAST SARCOMA; CASE REPORT; CYTOGENETICS; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GENE REARRANGEMENT; GENETIC ANALYSIS; GRANULOCYTIC SARCOMA; HUMAN; IMMUNOPHENOTYPING; NATURAL KILLER CELL; PHENOTYPE; PROTEIN EXPRESSION; STEM CELL; TUMOR LOCALIZATION;

EID: 0042834348     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/0031302031000150489     Document Type: Article

References (14)

1. Scott A, Head D, Kopecky K, et al. HLA-DR-, CD33+, CD56+, CDI6- myeloid/natural killer cell acute leukaemia: a previously unrecognised form of acute leukaemia potentially misdiagnosed as French-American-British acute myeloid leukaemia-M3. Blood 1994; 84: 244-55.
2. Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukaemia: a distinct hematolymphoid disease entity. Blood 1997; 90: 2417-28.
3. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leukemia Res 1999; 23: 615-24.
4. Burgaleta C, Miguel DD, Rubio ML, Krsnik I, Suarez JG. Myeloid natural killer cell leukemia resembling a variant of acute promyelocytic leukemia. Haematologica 2001; 86: 765-6.
5. Svaldi M, Moroder W, Messner H, et al. Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn. J Pediatr Hematol Oncol 2002; 24: 394-6.
6. Kahl C, Florschutz A, Leuner S, et al. CD7/CD56 double positive acute myelogenous leukemia. Lab Hematol 1999; 5: 1-6.
7. Thalhammer-Scherrer R MG, Simonitsch I, Jaeger U, Lechner K, Schneider B, Fonatsch C, Schwarzinger I. The immunophenotype of 325 adult acute leukaemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol 2002; 117: 380-9.
8. Aiba Y, Hiraama F, Ogawa M. Clonal proliferation and cytokine requirement of murine progenitors for natural killer cells. Blood 1997; 89: 4005-12.
9. Shibuya A, Nagayoshi K, Nakamura K, Nakauchi H. Lymphokine requirements for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1995; 85: 3538-46.
10. Byrd J, Dow NS, Gaertner E, et al. Leukemic thyroiditis as the initial relapsing sign in a patient with acute lymphoblastic leukemia and blast expression of the neural cell adhesion molecule. Am J Hematol 1997; 55: 212-5.
11. Hatano Y, Miura I, Horiuchi T. Cerebellar myeloblastoma formation in CD7-positive, neural cell adhesion molecule (CD56)-positive acute myelogenous leukaemia (M1). Ann Hematol 1997; 75: 125-8.
12. Zeromski J, Lawniczak M, Galbas K, Jenek R, Golusinski P. Expression of CD56/N-CAM antigen and some other adhesion molecules in various human endocrine glands. Folia Histochem Cytobiol 1998; 36: 119-25.
13. Nieman R, Barcos M, Costan B, et al. Granulocytic sarcoma: a clinicopathological study of 61 patients. Cancer 1981; 48: 1426-37.
14. Ngu IWY, Greenaway S, Greenberg ML. Unusual presentation of granulocytic sarcoma in the breast: a case report and review of the literature. Diagn Cytopathol 2000; 24: 53-7.